Frontlight ResearchEarly access
Trial site
Centre hospitalier universitaire de Tivoli Institut medical des Mutualites socialistes
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Crohn's disease2 trials
- Depression2 trials
- Atrial fibrillation1 trial
- Endometriosis1 trial
- Heart failure1 trial
- Multiple sclerosis1 trial
- Obesity1 trial
- Parkinson disease1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Status
- Completed7 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Janssen Cilag International2 trials
- Janssen Research & Development, LLC2 trials
- AbbVie1 trial
- AbbVie Deutschland GmbH & Co. KG1 trial
- Boehringer Ingelheim1 trial
- and 6 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Ulcerative colitis2 recruiting
- Heart failure1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026